The orthokeratology market is experiencing substantial growth as more individuals seek non-surgical alternatives to correct refractive errors. Orthokeratology, commonly referred to as Ortho-K, ...

Pentacam and corneal topography were more sensitive to tear film abnormalities when measuring the curvature of the cornea in ...

Three practitioners share their approaches to myopia management and highlight rewarding case studies. Emma White reports ...

Q2 2025 Earnings Call Transcript May 29, 2025 The Cooper Companies, Inc. beats earnings expectations. Reported EPS is $0.96, ...

The tear film coating the eye offers a window into a person's systemic and ocular health, carrying biomarkers such as glucose ...

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical.

Explore Q2 2025 insights for Cooper Companies (COO): 7% organic revenue growth, myopia management gains, cautious forecasts, and long-term optimism.

Myopia control lenses (glasses or contact lenses). They are part of a relatively new generation of optical treatments, ...

CooperVision announced the re-launch of its Science and Technology Awards Program, introducing a rolling submission model designed to accelerate and expand scientific collaboration. The longstanding ...

COO benefits from the strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise ...

Aims To evaluate the 1-year efficacy of two new myopia control spectacle lenses with lenslets of different asphericity. Methods One hundred seventy schoolchildren aged 8–13 years with myopia of −0.75 ...